Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation

Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis. The low solubility and permeability of this drug hinder its dermal administration. The purpose of this study was to design and cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarango-Granda, Paulo, Silva-Abreu, Marcelle, Calpena, Ana Cristina, Halbaut, Lyda, Fábrega, María-José, Rodríguez-Lagunas, María J., Díaz-Garrido, Natalia, Badia, Josefa, Espinoza, Lupe Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767333/
https://www.ncbi.nlm.nih.gov/pubmed/33371334
http://dx.doi.org/10.3390/ph13120484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767333/
https://www.ncbi.nlm.nih.gov/pubmed/33371334
http://dx.doi.org/10.3390/ph13120484

Ejemplares similares